60 Degrees Pharma reports 9.99% passive warrant stake

Blocker provisions exclude certain warrant shares when exercise would push beneficial ownership beyond 9.99% or 4.99%, depending on the warrant.

Available on EDGAR 11/10/2026 - 05:51 PM EST Accepted by SEC EDGAR 11/10/2026 - 05:50 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

60 Degrees Pharmaceuticals, Inc. (SXTP) is the issuer in an amended beneficial-ownership report stating that Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC each may have been deemed to beneficially own 390,342 shares, reported as 9.99%, as of September 30, 2026. The amount consists of 131,579 shares issuable under each of Intracoastal Warrants 1 and 2 and 127,184 shares issuable under Warrant 3. The reporting persons reported shared voting and dispositive power over 390,342 shares and zero sole power.

The percentage calculation uses 3,516,988 shares outstanding as of August 14, 2026, plus the shares issuable under the three warrants. Blocker provisions exclude additional warrant shares when exercise would cause beneficial ownership to exceed limits of 9.99% or 4.99%, depending on the warrant. The report states that without those blockers, each reporting person may have been deemed to beneficially own 690,685 shares.

Key Figures

Beneficial ownership reported for each reporting person: 390,342 shares Reported percentage of class: 9.99% Shares issuable under Intracoastal Warrant 1: 131,579 shares +4 more

7 metrics

Beneficial ownership reported for each reporting person 390,342 shares As of September 30, 2026

Reported percentage of class 9.99% Beneficial ownership as of September 30, 2026

Shares issuable under Intracoastal Warrant 1 131,579 shares Included in reported beneficial ownership

Shares issuable under Intracoastal Warrant 2 131,579 shares Included in reported beneficial ownership

Shares issuable under Intracoastal Warrant 3 127,184 shares Included in reported beneficial ownership

Common shares outstanding 3,516,988 shares As of August 14, 2026

Beneficial ownership without blocker provisions 690,685 shares The report states each reporting person may have been deemed to own this amount without the blockers

Key Terms

beneficial ownership, blocker provision, shared voting power, shared dispositive power

4 terms

beneficial ownership regulatory

"may have been deemed to have beneficial ownership of 390,342 shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

blocker provision regulatory

"contains a blocker provision under which the holder thereof does not have the right to exercise"

shared voting power regulatory

"Shared Voting Power 390,342.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power regulatory

"Shared Dispositive Power 390,342.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SXTP shares do Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC report owning?

As of September 30, 2026, each may have been deemed to beneficially own 390,342 shares of 60 Degrees Pharmaceuticals common stock, reported as 9.99% of the class. The three reporting persons report the same shared amount, not separate amounts to be added together.

Which SXTP warrants are included in the reported beneficial ownership?

The reported amount includes 131,579 shares issuable under Intracoastal Warrant 1, 131,579 under Warrant 2, and 127,184 under Warrant 3. Intracoastal Capital LLC holds the warrants.

What share amounts do the SXTP warrant blockers exclude?

The report excludes 64,387 shares issuable under Warrant 3 and 191,571 under Warrant 4 under 9.99% blockers. It also excludes 42 shares each under Warrants 5, 6, and 7, 25,465 under Warrant 8, and 18,794 under Warrant 9 under 4.99% blockers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

60 Degrees Pharmaceuticals, Inc.

(Name of Issuer)

Common stock, par value $0.0001 per share

(Title of Class of Securities)

83006G500

(CUSIP Number)

09/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 83006G500

1

Names of Reporting Persons

Mitchell P. Kopin

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 390,342.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 390,342.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

390,342.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP Number(s): 83006G500

1

Names of Reporting Persons

Daniel B. Asher

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 390,342.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 390,342.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

390,342.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP Number(s): 83006G500

1

Names of Reporting Persons

Intracoastal Capital LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 390,342.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 390,342.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

390,342.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: 60 Degrees Pharmaceuticals, Inc.
(b)	Address of issuer's principal executive offices: 1025 Connecticut Avenue NW, Suite 1000, Washington, D.C. 20036
Item 2.
(a)	Name of person filing: This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons").
(b)	Address or principal business office or, if none, residence: The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301.
(c)	Citizenship: Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company.
(d)	Title of class of securities: Common stock, par value $0.0001 per share
(e)	CUSIP No.: 83006G500
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: As of the close of business on September 30, 2026, each of the Reporting Persons may have been deemed to have beneficial ownership of 390,342 shares of Common Stock, which consisted of (i) 131,579 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal ("Intracoastal Warrant 1"), (ii) 131,579 shares of Common Stock issuable upon exercise of a second warrant held by Intracoastal ("Intracoastal Warrant 2") and (iii) 127,184 shares of Common Stock issuable upon exercise of a third warrant held by Intracoastal ("Intracoastal Warrant 3"), and all such shares of Common Stock represent beneficial ownership of approximately 9.99% of the Common Stock, based on (1) 3,516,988 shares of Common Stock outstanding as of August 14, 2026, as reported by the Issuer, plus (2) 131,579 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1, (3) 131,579 shares of Common Stock issuable upon exercise of Intracoastal Warrant 2 and (4) 127,184 shares of Common Stock issuable upon exercise of Intracoastal Warrant 3. The foregoing excludes (I) 64,387 shares of Common Stock issuable upon exercise of Intracoastal Warrant 3 because Intracoastal Warrant 3 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 3 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock, (II) 191,571 shares of Common Stock issuable upon exercise of a fourth warrant held by Intracoastal ("Intracoastal Warrant 4") because Intracoastal Warrant 4 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 4 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock, (III) 42 shares of Common Stock issuable upon exercise of a fifth warrant held by Intracoastal ("Intracoastal Warrant 5") because Intracoastal Warrant 5 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 5 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock, (IV) 42 shares of Common Stock issuable upon exercise of a sixth warrant held by Intracoastal ("Intracoastal Warrant 6") because Intracoastal Warrant 6 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 6 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock, (V) 42 shares of Common Stock issuable upon exercise of a seventh warrant held by Intracoastal ("Intracoastal Warrant 7") because Intracoastal Warrant 7 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 7 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock, (VI) 25,465 shares of Common Stock issuable upon exercise of an eighth warrant held by Intracoastal ("Intracoastal Warrant 8") because Intracoastal Warrant 8 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 8 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock and (VII) 18,794 shares of Common Stock issuable upon exercise of a ninth warrant held by Intracoastal ("Intracoastal Warrant 9") because Intracoastal Warrant 9 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 9 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock. Without such blocker provisions, each of the Reporting Persons may have been deemed to have beneficial ownership of 690,685 shares of Common Stock.
(b)	Percent of class: 9.99 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 390,342
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 390,342
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Mitchell P. Kopin

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin
Date:	11/10/2026

Daniel B. Asher

Signature:	/s/ Daniel B. Asher
Name/Title:	Daniel B. Asher
Date:	11/10/2026

Intracoastal Capital LLC

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin, Manager
Date:	11/10/2026